Taha Azad

Prix et distinctions

• (2025) Prix Jean-de-Margerie, Awarded for excellence in research. Université de Sherbrooke.
• (2024) Scholarships for the Next Generation of Scientists. Cancer Research Society. (Prize / Award).
• (2023) PART 1 – Postdoctoral Scholarship Award: Scholarships for the Next Generation of Scientists. Cancer Research Society. (Prize / Award).
• (2023) Terry Fox new investigator award. terry fox research institute. (Prize / Award).
• (2023) Worton Researcher in Training Award. Ottawa Hospital Research Institute. (Prize / Award).
• (2022) CIHR Fellowship. Canadian Institutes of Health Research. (Prize / Award).
• (2022) Mitacs Fellowship. Ottawa Hospital Research Institute. (Prize / Award).
• (2022) CIHR PDF. Canadian Institutes of Health Research. (Prize / Award).
• (2021) Banting Postdoctoral Fellowship. CIHR. (Prize / Award).
• (2021) Governor General's Gold Medal. Queens University. (Prize / Award).
• (2019) International Tuition Award-. Queen's University at Kingston. (Prize / Award).
• (2019) The Robert Kisilevsky Fund for Research Education. Queen's University at Kingston. (Prize / Award).
• (2019) One Gold and a Silver Medal for the best research in the CIHR National Student Research Competition. CIHR. (Prize / Award).
• (2019) Qualified in a global competition to participate in the 68th Lindau Nobel Laureate Meeting for young scientists. Lindau Nobel Laureate Meeting- http://www.cihr-irsc.gc.ca/e/50989.html. (Prize / Award).
• (2019) Vanier Canada Graduate Scholarships (Ranked 1st out of 190). CIHR. (Prize / Award).
• (2018) The Robert Kisilevsky Researech Award. Queen's University at Kingston. (Prize / Award).
• (2018) The Deans' Awards for Academic Achievement/Canadian Student Health Research Forum Awar. Queen's University at Kingston. (Prize / Award).
• (2018) Ontario Graduate Scholarship (the quota for Queen's University is only 6 students per year). Queen's University at Kingston. (Prize / Award).
• (2017) Queen’s Graduate Award, 2016-2017. Queen's University at Kingston. (Prize / Award).
• (2016) Queen’s Graduate Award, 2015-2016. Queen's University at Kingston. (Prize / Award).
• (2014) Ranked 1st student in M.Sc. Tarbiat Modares University. (Honor).
• (2014) Gold medal winner in the National Biology Olympiad. Ministry of Education. (Prize / Award).
• (2014) Member of the Iranian National Foundation of Elites. Presidency of Iran National Elites Foundation. (Prize / Award).
• (2007) Student Grant Award. National Congress on Medicinal Plants, Kish Island, Iran,. (Prize / Award).
• (2005) Ranked 2nd in the Nationwide University Entrance Exam among 18,612 participants in Iran. Ministry of Education. (Honor).
• (2005) Silver medal winner in the National Biology Olympiad. Ministry of Education. (Honor).
• FRQS Researcher-Scholar Award (Ranked 1 out of 48 applicants). Fonds de recherche du Québec - Santé (FRQS).

Financement

• (Awarded). Principal Investigator. Harnessing Antibiotics for Rapid Optimization of Cancer-Specific Vaccinia Oncolytic Virus (the entire fund is allocated towards T. Azad lab). Canadian Institutes of Health Research (CIHR). operating grant. 1 138 000 $. (2025-2030)
• (Awarded). Co-applicant. Development of an NLRC5-based broad spectrum immunotherapeutic for immune evasive cancers ($0 to Taha Azad Lab). Canadian Institutes of Health Research (CIHR). operating grant. 1 198 000 $. (2025-2030)
• Grant. (Awarded). Co-applicant. Harnessing blood-derived immune cells to overcome challenges in TIL therapy ($0 to Taha Azad Lab). Canadian Institutes of Health Research (CIHR). Operating grant. 1 009 800 $. (2025-2030)
• (Awarded). Co-applicant. Precision virotherapy to treat bladder cancer ($0 to Taha Azad Lab). Canadian Institutes of Health Research (CIHR). operating grant. 814 726 $. (2024-2029)
• Grant. (Awarded). Principal Investigator. Bioengineering viruses to create safer and more effective oncolytic viruses (Ranked 1 out of 70 in CBT panel, $197K/year, the entire $998K is allocated towards T. Azad lab). Canadian Institutes of Health Research (CIHR). Operating grant. 986 850 $. (2023-2028)
• (Awarded). Principal Applicant. Research Scholars - Junior 1 (Salary award, Ranked 1 out of 48 candidates). Fonds de recherche du Québec - Santé (FRQS). FRQSJ1. 255 000 $. (2024-2028)
• (Awarded). Principal Applicant. John R. Evans Leaders Fund. Canada Foundation for Innovation. John R. Evans Leaders Fund. 1 195 000 $. (2024-2026)
• Grant. (Awarded). Principal Applicant. Developing Novel Oncolytic Viruses as Therapeutic Tools for Pediatric Brain Tumors ($147K/year, the entire $442K is allocated towards T. Azad lab). Terry Fox Foundation (The). New investigator. 442 193 $. (2023-2025)
• Grant. (Completed). Principal Applicant. PART 2 – Operating Grant : Scholarships for the Next Generation of Scientists (Ranked 1st out of 12). Cancer Research Society. CRS NGS. 145 000 $. (2023-2025)
• Grant. (Awarded). Principal Applicant. Startup Fund. Université de Sherbrooke. Startup package. 170 000 $. (2023-2025)
• Grant. (Completed). Co-investigator. Development of an oncolytic virus expressing NLRC5-super activator (NLRC5-SA) for cancer. Institut de recherche sur le cancer de l'Université de Sherbrooke (IRCUS). Operating grant. 25 000 $. (2023-2024)
• Fellowship. (Completed). Co-investigator. Shaping the immunogenicity and efficient range of oncolytic vaccinia virus by the programmed release of therapeutically active, self-amplifying RNA containing virus-like-particles. Mitacs. Mitacs Elevate. 130 000 $. (2022-2024)
• Grant. (Completed). Co-investigator. Development of Vaccines to Prevent SARS-CoV-2 Infection in High Risk Individuals. Canadian Institutes of Health Research (CIHR). Fast response. 1 936 150 $. (2020-2023)
• Grant. (Completed). Collaborator. Establishment of NanoLuc complementation reporter-based biosensor for measuring ACE2 and SARS-CoV-2 spike protein receptor-binding domain (RBD) interaction. Canadian Institutes of Health Research (CIHR). Fast response. 440 000 $. (2020-2022)
• Fellowship. (Completed). Principal Applicant. Combined oncolytic virotherapy and RTKs signaling targeting for cancer treatment- Banting Postdoctoral Fellowship. Canadian Institutes of Health Research (CIHR). Banting PDF. 140 000 $. (2020-2021)
• Grant. (Completed). Co-applicant. Development of a biosensor for high throughput screening of novel compounds targeting ezrin for breast cancer therapy. Canadian Cancer Society Research Institute (CCSRI). CCSRI innovation grant. 200 000 $. (2018-2020)
• Fellowship. (Completed). Co-applicant. Mitacs Accelerate Fellowship. Mitacs. Mitacs accelerate. 45 000 $. (2019-2020)
• Scholarship. (Completed). Principal Applicant. Vanier Canada Graduate Scholarships. Canadian Institutes of Health Research (CIHR). Vanier-Banting program. 150 000 $. (2017-2019)
• Scholarship. (Completed). Principal Applicant. Ontario Graduate Scholarship. Ministry of Colleges and Universities. Ontario Graduate Scholarship (OGS) Program. 15 000 $. (2017-2018)
• Scholarship. (Completed). Principal Applicant. Ontario Graduate Scholarship. Ministry of Colleges and Universities. Ontario Graduate Scholarship (OGS) Program. 15 000 $. (2015-2016)

Publications

Articles de revue

• Y. Gholami, B. Darki, M. Isfahani; K. Jafari; T. Azad. (2025). An Ultrasensitive MOEMS Platform Relied on an Adjustable Defect Width for Label-Free Bioparticle Detection. IEEE Sensors Journal 25 17309 - 17316.
• R. Rezaei, S. Boulton, M. Ahmadi, J. Petryk, M. Da Silva, N. Kooshki Zamani, R. Singaravelu, G. St-Laurent, L. Daniel, A. Sadeghipour, A. Pelin, J. Poutou, A. I. Munoz Zuniga, C. Choy, V. H. Gilchrist, Z. Khalid, B. Austin, K. A. Onsu, R. Marius, Z. Ameli, F. Mohammadi, V. Mancinelli, E. Wang, A. Nik-Akhtar, A. Alwithenani, F. Panahi Arasi, S. Ferguson, T. C. Hobman, T. Alain, L. H. Tai, C. Ilkow, J.-S. Diallo, J. C. Bell, T. Azad. (2024). Antibiotic-Mediated Selection for Generating Randomly Mutagenized and Targeted Cytokine-Expressing Oncolytic Viruses (50% NSE). Nature Biomedical Bioengineering 32 57-110. (Published).
• S. Takallou, M. Hajikarimlou, M. Al‐gafari, J. Wang, S. Jagadeesan, T. Kazmirchuk, H. Moteshareie, A. Indrayanti, T. Azad, M. Holcik, B. Samanfar, M. Smith, A. Golshani. (2024). Hydrogen peroxide sensitivity connects the activity of COX5A and NPR3 to the regulation of YAP1 expression (100% NSE). The FASEB Journal 38 e23439. (Published).
• S. Nasim Mirbahari, M. Silva, A. Zúñiga, N. Zamani, G. Laurent, M. Totonchi, T. Azad. (2024). Recent progress in combination therapy of oncolytic vaccinia virus. Frontiers in Immunology 15 1272351. (Published).
• F. Marvi, K. Jafari, M. Shahabadi, M. Tabarzad, F. Ghorbani-Bidkorpeh, T. Azad. (2024). Ultrasensitive detection of vital biomolecules based on a multi-purpose BioMEMS for Point of care testing: digoxin measurement as a case study (100% NSE). Scientific Reports 14 (1), 1633-1648. (Published).
• T. Azad, R. Rezaei, R. Singaravelu, A. Pelin, S. Boulton, J. Petryk, K. Onsu, N. T. Martin, V. Hoskin, M. Ghahremani, M. Marotel, R. Marius, X. He, M. J. F. Crupi, H. Hoang, A. Nik-Akhtar, M. Ahmadi, N. Zamani, A. Golshani, T. Alain, P. Greer, M. Ardolino, B. C. Dickinson, L-H. Tai, C. S. Ilkow & J. C. Bell. (2023). Nature Communications 14 30-88. (Published).
• S. Boulton, J. Poutou, R. Gill, N. Alluqmani, X. He, R. Singaravelu, M. Crupi, J. Petryk, B. Austin, I. Teo, S. Singh, R. Jamil, R. Marius, N. Martin, T. Jamieson, T. Azad, Diallo, C. S. Ilkow, J. Bell. (2023). A T cell-targeted multi-antigen vaccine generates robust cellular and humoral immunity against SARS-CoV-2 infection (30% NSE). Molecular Therapy-Methods & Clinical Development 14 234-266. (Published).
• J. T Whelan, R. Singaravelu, F. Wang, Adrian Pelin, L. A Tamming, G. Pugliese, N. T Martin, M. Crupi, Julia Petryk, B. Austin, X. He, R. Marius, C. Jones, E. F. Brown, N. Alluqmani, A. Chen, S. Boulton, M. Huh, M. Y Tang, E. Scut, J. Diallo, T. Azad, B. D Lichty, C S Ilkow and J Bell. (2023). CRISPR-mediated rapid arming of poxvirus vectors enables facile generation of the novel immunotherapeutic STINGPOX (40% NSE). Frontiers in immunology 287 567-599. (Published).
• S. Ferková, U. Froehlich, M. Nepveu-Traversy, A. Murza, T. Azad, M. Grandbois, P. Sarret, P. Lavigne, P. Boudreault. (2023). Comparative Analysis of Cyclization Techniques in Stapled Peptides: Structural Insights into Protein–Protein Interactions in a SARS-CoV-2 Spike RBD/hACE2 Model System. International Journal of Molecular Sciences 25 (1), 166-196. (Published).
• N. T. Martin, M. J. F. Crupi, Z. Taha, J. Poutou, J. Whelan, S. Vallati, J. Petryk, R. Marius, B. Austin, T. Azad, M. Boulanger, T. Burgess, I. Sanders, C. Victoor, B. C. Dickinson, J-S Diallo, C. S. Ilkow and J. C. Bell. (2023). Engineering Rapalog-Inducible Genetic Switches Based on Split-T7 Polymerase to Regulate Oncolytic Virus-Driven Production of Tumour-Localized IL-12 for Anti-Cancer Immunotherapy. Pharmaceuticals 16 (5), 709-732. (Published).
• A. Surendran, M. Jamalkhah, J. Poutou, R. Birtch,C. Lawson, J. Dave, M. Crupi, V. Taylor, J. Petryk, C. Souza, N. Moodie, J. Billingsley, B. Austin, N. Cormack, N. Blamey, R. Rezae, C. Mccloskey, E. Fekete, H. Birdi, S. Neault, T. Jamieson, S. Tucker, T. Azad, B. Vanderhyden, L. Tai, J. Bell, C. Ilkow. (2023). Fatty acid transport protein inhibition sensitizes breast and ovarian cancers to oncolytic virus therapy via lipid modulation of the tumor microenvironment. Frontiers in Immunology 255 151-191. (Published).
• S. Boulton, M. Crupi, S. Singh, M. Timofte, T. Azad, B. C Organ, X. He, R. Gill, S. Neault, T. Jamieson, J. Dave, N. Kurmasheva, B. Austin, J. Petryk, R. Singaravelu, B. Huang, N. Franco, K. Babu, R. J Parks, C. S Ilkow, D. Olagnier, J. C Bell. (2023). Inhibition of exchange proteins directly activated by cAMP as a strategy for broad-spectrum antiviral development (100% NSE). Journal of Biological Chemistry 299 (6), 255-289. (Published).
• T. Kazmirchuk, C. Jost, T. Withey, T. Gessese, T. Azad, B. Samanfar, F. Dehne and A. Golshani. (2023). Peptides of a Feather: How Computation Is Taking Peptide Therapeutics under Its Wing. Genes 14 11-94. (Published).
• Hajikarimlou M, Hooshyar M, Moutaoufik MT, Aly KA, Azad T, Takallou S, Jagadeesan S, Phanse S, Said KB, Samanfar B, Bell JC. (2022). A computational approach to rapidly design peptides that detect SARS-CoV-2 surface protein S (100% NSE). NAR genomics and bioinformatics 44 11-56. (Published).
• S. Ghavami, P. Abrishami, S. Afifi, A. Sereshki, M. Akbari, A. Akbariansaravi, E. Alarcon, A. Alavi, P. Alipour, T. Azad, Z. Azizi, Majid Bahrami, M. Balibegloo, A. Baniasadi, et al. (2022). Diversity, equity and inclusion in autophagy research. Autophagy 59 1232-1249. DOI. (Published).
• Z. Taha, R. Arulanandam, G. Maznyi, E. Godbout, M. E. Carter-Timofte, N. Kurmasheva, L. S. Reinert, A. Chen, M. J.F. Crupi, S. Boulton, G. Laroche, A. Phan, N. Alluqmani, A. Jirovec, A. Acal, E.F. Brown, R. Singaravelu, J. Petryk, M. Idorn, K. G. Potts, H. Todesco, D. J. Mahoney, C. S. Ilkow, P. Giguère, T. Alain, M. Côté, S. R. Paludan, D. Olagnier, J. C. Bell, T. Azad (senior author) and J-S Diallo. (2022). Identification of FDA-approved Bifonazole as SARS-CoV-2 blocking agent following a bioreporter drug screen. Molecular Therapy-Cell 675 32. (Published).
• M. Crupi, Z. Taha, T. Janssen, J. Petryk, S. Boulton, N. Alluqmani, A. Jirovec, O. Kassas, S. Khan, S. Vallati, E. Lee, B. Zhen Huang, M. Huh, L. Pikor, X. He, R. Marius, B. Austin, J. Duong, A. Pelin, S. Neault, T. Azad, C. J. Breitbach, D. F. Stojdl, M. F. Burgess, S. McComb, R. Auer, J. Diallo, C. S. Ilkow and J. Bell. (2022). Oncolytic virus driven T-cell-based combination immunotherapy platform for colorectal cancer. Frontiers in immunology 123 456-491. (Published).
• T. Azad, R. Rezaei,..., J. Cowan, D. Cameron, C. S. Ilkow,. (2021). A High-Throughput NanoBiT-Based Serological Assay Detects SARS-CoV-2 Seroconversion. Nanomaterials 11 807-821. (Published).
• Carter-Timofte, M.; Arulanandam, R.; Kurmasheva , N.; Taha, Z.; Cassin, L.; Jacobs, D.; Maznyi, G.; Azad, T., Manja; P., Soren; Bell, J.; Seguin, J.; Sabourin, L.; Cote, M.; Diallo, JS; Alain, T.; Olagnier, D. (2021). Antiviral Potential of the Antimicrobial Drug Atovaquone against SARS-CoV-2 and Emerging Variants of Concern. ACS Infectious Diseases 7 23-45. (Published).
• E. Brown, R. Rezaei, T. Jamieson, J. Dave, N. Martin, R. Singaravelu,..., J. Diallo, J. Bell, C. S. Ilkow, T. Azad. (2021). Characterization of Critical Determinants of ACE2–SARS CoV-2 RBD Interaction (100% NSE). International Journal of Molecular Sciences 7 1-25. (Published).
• T. Jamieson, J. Poutou, R. Marius, X. He, R. Rezaei, T. Azad, CS. Ilkow. (2021). Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection. Journal of Visualized Experiments 43 56-98. (Published).
• R. Rezaei, A. Surendran, R. Singaravelu, T. Jamieson, P. Taklifi, J. Poutou, T. Azad, Carolina S. Ilkow,. (2021). Detection of SARS-CoV-2 Receptor-Binding Domain Antibody using a HiBiT-Based Bioreporter. Journal of Visualized Experiments 76 54-59. (Published).
• M. Razzaghi, A. Homaei, F. Vianello, T. Azad, T. Sharma, Ashok K. Nadda, R. Stevanato, M. Bilal, and H. Iqbal. (2021). Industrial applications of immobilized nano-biocatalysts (100% NSE). Bioprocess and Biosystems Engineering 138 1-15. (Published).
• T. Azad, H. Rensburg, J. Morgan, R. Rezaei, M. Crupi, R Chen, M. Ghahremani, M. Jamalkhah, N. Forbes, C. Ilkow, J. Bell. (2021). Luciferase-based biosensors in the era of the COVID-19 pandemic. ACS Nano / Nano au 1 1-29. (Published).
• T. Azad, R. Singaravelu, Z. Taha, T. Jamieson, S. Boulton, M.Crupi, N. Martin, E. Brown, J. Poutou, M. Ghahremani, A. Pelin, K. Nouri, R. Rezaei, A. Gingras, D. Cameron, P. Greer, C. S. Ilkowa, J. Dialloa, J. C. Bell. (2021). Nanoluciferase complementation-based biosensor reveals the importance of N- linked glycosylation of SARS-CoV-2 Spike for viral entry (100% NSE). Molecular Therapy-Cell Press 29 1984-2000. (Published).
• M. Power, T. Azad, J. Bell, A. MacLean. (2021). Plant-based expression of SARS-CoV-2 antigens for use in an oral vaccine. Journal of Food Science and Nutrition 65 33-38. (Accepted).
• T. Azad, R. Singaravelu, E. Brown, Z. Taha, R. Rezaei, R. Arulanandam, S. Boulton, J-S Diallo, C. S.Ilkowab, J.Bell. (2021). SARS-CoV-2 S1 NanoBiT: A nanoluciferase complementation-based biosensor to rapidly probe SARS-CoV-2 receptor recognition. Biosensors and Bioelectronics 180 113122-113139. (Published).
• S. Boulton, Y. Poutou Paumier, N. Martin, T. Azad (first equal contribution), R. Singaravelu, M. Crupi, T. Jamieson, X. He, R. Marius, J. Petryk, C. Souza, B. Austin, S. Khan, A. Pelin, R. Rezaei, A Surendran, J. Diallo, R. Auer, J. Angel, D. Cameron, R. Lapointe, K. Potts, D. Mahoney, J. Bell, C. Ilkow. (2021). Single dose replicating poxvirus vector-based RBD vaccine drives robust humoral and T cell immune response against SARS-CoV-2 infection. Molecular Therapy - Cell 787 7876-7898. (Published).
• A. Sadremomtaz, M. Al-Dahmani, A. Ruiz-Moreno, A. Monti, C. Wang,T. Azad, J. Bell, N. Doti, M. Velasco,J. de Jong, S. Alexander, H. Goor, Harry, M. Groves, Matthew. (2021). Synthetic Peptides that antagonise the Angiotensin-Converting Enzyme-2 (ACE-2) interaction with SARS-CoV-2 receptor binding spike protein (100% NSE). Journal of Medicinal Chemistry 87 878-898. (Published).
• M Wedge, V. Jennings, M Crupi, J Poutou, T. Jamieson, G. Pugliese, C. Souza, J. Petryk, B. Laight, M. Boileau, N. Alluqmani, H. E. McKay, L. Pikor, S. Tahsin Khan, T. Azad, R. Rezaei, B. Austin, X. He, D. Mansfield, A. Pelin, E Rose, E. Brown, N. Crawford, A. Alkayyal, A. Surendran, R. Singaravelu, D. G. Roy, B. McSweeney, M. Cottee, E. J. Jacobus, B. Geoffrion, K. J. Rayner, A. Chatterjee, Rebecca G. Migneco, M. C. Auer, Jean-Simon Diallo, D. Gibbings, B. Oever, A. Melcher, J C. Bell, and C. S. Ilkow. (2021). Virally programmed extracellular vesicles sensitize cancer cells to oncolytic virus and small molecule therapy. Nature Communications 78 1-32. (Published).
• T. Azad, R. Rezaei, A. Surendran, R. Singaravelu, S. Boulton, J. Dave, J. Bell and C. S. Ilkow . (2020). Hippo Signaling Pathway as a Central Mediator of Receptors Tyrosine Kinases (RTKs) in Tumorigenesis. Cancers 13 10. (Published).
• T. Azad, R. Singaravelu, M.F. Crupi, T. Jamieson, J. Dave, E.F. Brown, R. Rezaei, Z. Taha, S. Boulton, N. Martin, A. Surendran, J. Poutou, M. Ghahremani, K. Nouri, J. Whelan, J. Duong, S. Tucker, J. Diallo, J. C. Bell and C. S. Ilkow. (2020). Implications for SARS-CoV-2 Vaccine Design: Fusion of Spike Glycoprotein Transmembrane Domain to Receptor-Binding Domain Induces Trimerization. Membranes - -. (Published).
• X. Guo , Y. Sun , T. Azad , H. Rensburg , J. , S. , P. Liu , Z. Lv , M. Zhan , L. Lu , Y. Zhou , X. Ma , X. Zhang , X. Yang , L. Xue. (2020). Rox8 promotes miRNA-dependent yki mRNA decay (100% NSE). Proceedings of the National Academy of Sciences of the United States of America (PNAS) 10 25. (Published).
• T. Azad, K. Nouri, H. J Janse van Rensburg, S. M. Maritan, T. Montminy, Y. Hao, J. Yu, P. Khanal, L. M. Mulligan, X. Yang. (2019). A gain-of-functional screen identifies the Hippo pathway as a central mediator of receptor tyrosine kinases during tumorigenesis. Oncogene-Nature Series 15 18. (Published).
• K. Nouri, T. Azad (equal contribution first author), E. Lightbody, P. Khanal, C. Nicol, X. Yang. (2019). A kinome-wide screen using a NanoLuc LATS luminescent biosensor identifies ALK as a novel regulator of the Hippo pathway in tumorigenesis and immune evasion. FASEB Journal - 46. (Published).
• K. Nouri; T. Azad; M. Ling; Janse H van Rensburg; H. Shen; J. Zhang, X. Yang. (2019). Identification of Celastrol as a novel YAP-TEAD inhibitor for cancer therapy by high throughput screening with ultrasensitive YAP/TAZ-TEAD biosensors. Cancers 13 25. (Published).
• T. Azad, M. Ghahremani, X. Yang. (2019). The Role of YAP and TAZ in Angiogenesis and Vascular Mimicry (50% NSE). Cells 87 407-429. (Published).
• T. Azad , H. J Rensburg , E. Lightbody, B. Naveu , A. Champagne , A. Ghaffari , V. Kay , Y. Hao , H. Shen , B. Yeung , A. Croy , K. Guan , F. Pouliot , J. Zhang , C. Nicol, X. Yang. (2018). A LATS biosensor screen identifies VEGFR as a regulator of the Hippo pathway in angiogenesis (50% NSE). Nature Communications 24 1061-1070. (Published).
• T. Azad, K. Nouri (equal contribution), H. J. Rensburg, Y. Hao, X. Yang. (2018). Monitoring Hippo Signaling Pathway Activity Using a Luciferase-based Large Tumor Suppressor (LATS) Biosensor. JoVE | Peer Reviewed Scientific Video Journal - Methods and Protocols 18 1-6. (Published).
• Y. Zhao , T. Montminy , T. Azad (equal contribution),E. Lightbody , Y. Hao , S. SenGupta , E. Asselin , C. J. Nicol. (2018). PI3K Regulates YAP/TAZ in Mammary Tumorigenesis through Multiple Signaling Pathways. Molecular Cancer Research 26 1046-1058. (Published).
• H. Rensburg, D. Lai, T. Azad (equal contribution), Y. Hao, Xi. Yang. (2018). TAZ enhances mammary cell proliferation in 3D culture through transcriptional regulation of IRS1 (50% NSE). Cellular Signalling 14 12-22. (Published).
• H. J Rensburg, T. Azad, M. Ling, Y. Hao, B. Snetsinger, P. Khanal, L. M Minassian, C. H. Graham, M. J Rauh and X. Yang. (2018). The Hippo pathway component TAZ promotes immune evasion in human cancer through PD-L1. Cancer Research-AACR Publications 13 31-39. (Published).
• T. Bahmani ; S. Gholami; A. Mostafaie; E. Karimi; Z. Hoseinkhani; T. Azad; H. Mahdizadeh & K. Mansouri. (2017). Olfactory Epithelium as an Infinitive Source of Neural Stem Cells for Derivation of Inner Ear Hair Cells (50% NSE). International Journal of Morphology 11 413-419. (Published).
• S.Rouholamini, N.Motamed, E.Birjandian, T.Azad, K.Omidfar. (2015). Inhibition of mir-15a Gene Expression by Silibinin in MCF-7 Breast Cancer Cell Line. International Journal of Current Research and Academic Review 12 288-296. (Published).
• R.Hemmati, S.Hosseinkhani, R.Sajedi, T.Azad, A.Tashakor, N.Bakhtiari, F.Ataei. (2015). Luciferin Regenerating Enzyme mediatesfirefly luciferase activation through direct effects of D-cysteine onluciferase structure and activity. Photochemistry and Photobiology 13 828–836. (Published).
• T.Azad, A.Tashakor, F.Rahmati, R.Hemmati, S.Hosseinkhani. (2015). Oscillation of apoptosome formation through assembly of truncated Apaf-1. European Journal of Pharmacology 21 64-71. (Published).
• T. Azad, A.Tashakor, M.Ghahremani, R.Hemmati, F.Ataei, S. Hosseinkhani. (2014). Apoptotic protease-activating factor 1 as a liable gene for spontaneous mutations in vitro. Progress in Biological Science 5 261-273. (Published).
• T.Azad, A.Tashakor, R.Hemmati, S.Hosseinkhni. (2014). Investigation the effect of an Apaf-1 derivative on caspasein HEK293T cells. Teb journal 3 57-65. (Published).
• M. Ghahremani, F. Ghanati, F. Bernard, T. Azad, M. Gholami, M. Safari. (2014). Ornithine-induced increase of proline and polyamines contents in tobacco cells under salinity conditions. Australian Journal of Crop Science 6 91-96. (Published).
• T.Azad, A.Tashakor, S.Hosseinkhani. (2014). Split-luciferase complementary assay: Applications, recent developmentsand future perspectives. Analytical and Bioanalytical Chemistry 16 5541-5560. (Published).
• M.Ghahremani, F.Ghanati, F.Bernard, M.Gholami, T.Azad. (2013). Effects of exogenous ornithine enantiomerson tobacco cells under salinity conditions. Progress in biological Science 87 100-107. (Published).

Livres

• E. khosravi,T. Azad,. (2019). Comparative animal biology for High school students- Tehran, Iran, ISBN 978-964-355-713-3. Iran : Razamandegan publications. (Published).
• T. Azad, R. Khanjari. (2018). Basic Biology for High School Students,Tehran, Iran, 2014, ISBN 978-600-5008-79-1. Iran : Kelke Moalem. (Published).
• A. Nasri, K. Nasri. (2018). General Biology for High School Students, Tehran, Iran, ISBN:9786005506716. Iran : Kheili Sabz. (Published).
• A. Tashakor, R. Hemmati, T. Azad. (2017). Biochemistry-Biophysics and Genetic Engineering, ISBN:9786006531670. Iran : Sobhan. (Published).
• T. Azad, M. Tokazebani, M. Khakie, M. Manteghi. (2017). Genetics for High School Students, Tehran, Iran, 2014, ISBN 978-600-5008-66-1. Iran : Kelk publications. (Published).
• T. Azad, M. Hosseinpour, M. Sharifian. (2010). General biology for college students (Volume1), Tehran, Iran, 2014, ISBN 978-600-5703-12-2. Taimaz. (Published).
• T. Azad, S. Abarghoe, A. Taghi, P. Abolahi. (2010). General biology for college students (Volume 2), Tehran, Iran, 2014, ISBN 978-600-5703-13-9. Taimaz. (Published).
• A. Shaghaiegh, M. Hadadi, H. Rahvareh, A. Keramat, H. Komshi,. (2010). The Biology Coloring Book- Tehran, Iran, ISBN 978-600-126-332-3. Ghalamchi. (Published).
• Sh. Shahdin, T. Azad, and others. (2009). How to Prepare for Iranian University Entrance Exam (Volume 1)-Tehran, Iran, 2014, ISBN 9786001263712. Ghalamchi. (Published).
• Sh. Shahdin, T. Azad, and others. (2009). How to Prepare for Iranian University Entrance Exam (Volume 2)-Tehran, Iran, 2014, ISBN 97869645097842. Ghalamchi. (Published).

Articles de magazine

• T.Azad. (2010). How to succeed in the Iranian National Biology exam. Azmon.
• T.Azad. (2009). How DNA Structure was discovered?. Dena (monthly biology magazine at University of Tehran (Iran).

Propriétés intellectuelles

Patents

• Xiaolong Yang Taha Azad Kazem Nouri. (2023). HIPPO PATHWAY BIOLUMINESCENT BIOSENSOR- YANG, Xiaolong; AZAD Taha; NOURI Kazem. 16177691. Canada. (Granted/Issued).
• ILKOW, Carolina, Solange; BELL, John, Cameron; WHELAN, Jack, Timothy; CRUPI, Mathieu, François, Joseph; DUONG, Jessie, Nhan; LICHTY, Brian, Dennis; ATHERTON, Matthew, John; WANG, Fuan; PAUMIER, Yoana, Poutou; BOULTON, Stephen, Donald; AZAD, Taha; SINGARAVELU, Ragunath. RECOMBINANT POLYPEPTIDES FOR PROGRAMMING EXTRACELLULAR VESICLES. CA2020/051630. United States of America. (Granted/Issued).

Autres contributions

Présentations

• (2025). Lighting up cancer research with firefly proteins. Winter School in Precision Oncology. Orford, Canada
• (2025). Rapid Antibiotic-Guided Engineering of Oncolytic Viruses for Enhanced Cancer Immunotherapy. 2025 XXV International Poxvirus, Asfarvirus, and Iridovirus Conference. United States of America
• (2024). Developing the next generation of immunotherapies. 5th International Cancer Conference: From Bench to Bedside. Tehran, Iran
• (2024). Harnessing Antibiotics as Tools for High-throughput Insertional Mutagenesis and Generating Cytokine-Expressing Oncolytic Virus Libraries. international oncolytic virus conference. Netherlands
• (2023). Synthetic virology approaches in oncolytic virotherapy. Canadian Cancer Research Conference, Halifax. Canada
• (2022). Conditionally replicating vaccinia virus platforms As alternatives to Modified Vaccinia Ankara for cancer immunotherapy. International oncolytic virus conference. Japan
• (2022). Synthetic Biology: novel strategies for discovering new cancer therapeutics. Terry Fox Research Institute and Princess Margaret Cancer Centre Symposium. Toronto, Canada
• (2021). Viral genome editing reveals non-essential genes in the development of a safe and efficient oncolytic platform. XXIII International Poxvirus, Asfarvirus, and Iridovirus Conference. Pennsylvania, United States of America
• (2020). Nanoluciferase complementation-based biosensor reveals the importance of N- linked glycosylation of SARS-CoV-2 Spike for viral entry. The Ottawa Hospital Research Institute Research Day. Ottawa, Canada
• (2017). How Fireflies could be the key to fighting cancer?. Banting-Vanier Lecture Series https://www.queensu.ca/sgs/banting-vanier-lecture-series. Kingston, Canada
• (2017). Identification of Novel Receptor Tyrosine Kinases (RTKs) Regulating the Hippo Signaling Pathway in Tumorigenesis (CIHR Gold Award Winner), Taha Azad, Helena Janse van Rensburg, Yawei Hao, Yang X. CIHR National Student Research Poster Competition. Winnipeg, Canada
• (2016). "Identification of FGFR1 as a novel kinase regulating YAP oncoprotein", (CIHR Gold Award Winner), H. Janse van Rensburg, T.Azad (equal contribution) , J. Yu , Y. Hao, Kl. Guan, X. Yang. CIHR National Student Research Poster Competition. Winnipeg, Canada
• (2016). “Detection of protein-protein interaction and intramoleculat conformational changes in Apaf-1 using split luciferase complementation assay”, A. Tashakor, M. Hosseinzadehkordi, T. Azad,. Protein Interaction in Biology, National University of Ireland. Galway, Ireland
• (2014). "Split Luciferase Complementation Assay",Best English presentation award. 10th annual Meeting of the Biological Society. Tehran, Iran
• (2013). "Design and characterization of a new firefly luciferase mutant by site-directed mutagenesis", A. Tashakor, T. Azad, S. Hosseinkhani, F. Jazayeri, M.A. Nasab. National Congress of Biological Sciences. Isfahan, Iran
• (2013). "Detection Protein Protien Interaction, Using Firefly Luciferase", Best Poster Award,. 1st International Life Science Conference & 12th Iran Biophysical Chemistry Conference. Tabriz, Iran
• (2013). "Investigation on the function of WD-40 domain in Apaf -1(apoptosis factor) by split luciferase complementation assay", T. Azad, A. Tashakor, S. Hosseinkhani, F. Ataei, M.T. Mahani. National Congress of Biological Sciences. Isfahan, Iran
• (2013). "Role of electrostatic interactions in switching autoinhibited Apaf-1 molecule into active state", A. Tashakor, T. Azad, S. Hosseinkhani, F. Ataei, M.T. Mahani. National Congress of Biological Sciences. Isfahan, Iran
• (2013). "Site-directed mutagenesis of firefly luciferase: Effect of Charge Distribution on active site",T. Azad, A. Tashakor, S. Hosseinkhani, F. Jazaieri, M.A. nasab. National Congress of Biological Sciences. Isfahan, Iran
• (2013). “Effect of exogenous D-ornithine on antioxidant enzymes, viability, and growth of tobacco cells under salinity stress”, M. Ghahremani, F. Ghanati, T. Azad. 1st International Life Science Conference & 12th Iran Biophysical Chemistry Conference,. Tabriz, Iran
• (2013). “Effect of exogenous D/L-ornithine on growth and putrescine and spermidine contents of tobacco cells (Nicotiana tabacum L. CV. Burley 21) under salinity stress”, M. Ghahremani, F. Ghanati, T. Azad. National Congress of Biological Science. Isfahan, Iran
• (2012). “A plausible relationship between D-ornithine and resistance to salt stress in tobacco (Nicotiana tabacum L.) cells”, M. Ghahremani, F. Ghanati, T. Azad. National Congress on Medicinal Plants,. Kish Island, Iran
• (2012). “Changes in proline content and lipid peroxidation level by salinity stress and D-ornithine application in tobacco (Nicotiana tabacum L.)”M. Ghahremani, F. Ghanati, T. Azad. 3rd Iranian Agricultural Biotecnology Conference. Mashhad, Iran